Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mark R. Gilbert, MD
M.D. Anderson Cancer Center
Principal Investigator - Roger Stupp, MD
Centre Hospitalier Universitaire Vaudois
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
351 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tom Baker Cancer Centre - Calgary
Calgary, Alberta, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- Saint John Regional Hospital
Saint John, New Brunswick, Canada
- Margaret and Charles Juravinski Cancer Centre
Hamilton, Ontario, Canada
- Ottawa Hospital Regional Cancer Centre - General Campus
Ottawa, Ontario, Canada
- Cancer Care Program at Thunder Bay Regional Health Sciences
Thunder Bay, Ontario, Canada
- Princess Margaret Hospital
Toronto, Ontario, Canada
- Mcgill Cancer Centre at Mcgill University
Montreal, Quebec, Canada
- Centre Hospitalier Universitaire de Quebec
Québec, Quebec, Canada
- Allan Blair Cancer Centre at Pasqua Hospital
Regina, Saskatchewan, Canada
- Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital
Fairbanks, Alaska, United States
- Arizona Oncology Services Foundation
Phoenix, Arizona, United States
- Mayo Clinic Scottsdale
Scottsdale, Arizona, United States
- Arizona Oncology - Tucson
Tucson, Arizona, United States
- Auburn Radiation Oncology
Auburn, California, United States
- Providence Saint Joseph Medical Center - Burbank
Burbank, California, United States
- Radiation Oncology Centers - Cameron Park
Cameron Park, California, United States
- Mercy Cancer Center at Mercy San Juan Medical Center
Carmichael, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Kaiser Permanente Medical Center - Los Angeles
Los Angeles, California, United States
- Radiation Oncology Center - Roseville
Roseville, California, United States
- Mercy General Hospital
Sacramento, California, United States
- Radiological Associates of Sacramento Medical Group, Incorporated
Sacramento, California, United States
- Ucsf Helen Diller Family Comprehensive Cancer Center
San Francisco, California, United States
- Solano Radiation Oncology Center
Vacaville, California, United States
- Penrose Cancer Center at Penrose Hospital
Colorado Springs, Colorado, United States
- Poudre Valley Radiation Oncology
Fort Collins, Colorado, United States
- Yale Cancer Center
New Haven, Connecticut, United States
- Tunnell Cancer Center at Beebe Medical Center
Lewes, Delaware, United States
- Ccop - Christiana Care Health Services
Newark, Delaware, United States
- Eugene M. and Christine E. Lynn Cancer Institute at Boca Raton Community Hospital - Main Campus
Boca Raton, Florida, United States
- University of Florida Shands Cancer Center
Gainesville, Florida, United States
- Baptist Cancer Institute - Jacksonville
Jacksonville, Florida, United States
- Baptist Medical Center South
Jacksonville, Florida, United States
- Integrated Community Oncology Network at Southside Cancer Center
Jacksonville, Florida, United States
- Mayo Clinic - Jacksonville
Jacksonville, Florida, United States
- Integrated Community Oncology Network
Jacksonville Beach, Florida, United States
- Baptist-South Miami Regional Cancer Program
Miami, Florida, United States
- Integrated Community Oncology Network - Orange Park
Orange Park, Florida, United States
- Florida Cancer Center - Palatka
Palatka, Florida, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2006
- Primary completion
- 28 Feb 2011
- Completion
- 31 Dec 2016
- Last update posted
- 9 Jun 2020
- Registered enrollment
- 1,173
- Registry id
- NCT00304031
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.